Riskpilot← Back to searchSign inGet full accessProTreatment Herlev ApS
APSActiveCVR 38427288Stationsalleen 42Physiotherapy activities · NACE 8695Est. 20175 employees
Revenue 2024
DKK 4M
+36% vs 2023
EBITDA margin
54.3%
-16% vs 2023
Equity ratio
12.9%
Financial strength
Net profit 2024
DKK 888K
-28% vs 2023
| Revenue | DKK 4M | +36% |
| EBITDA | DKK 2,2M | -16% |
| Net profit | DKK 888K | -28% |
| Total assets | DKK 9,8M | +14% |
| Equity | DKK 1,3M | -20% |
| Employees | 5 | — |
Legal name
ProTreatment Herlev ApS
CVR number
38427288
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
20. februar 2017
Share capital
DKK 50.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller af den samlede direktion.
Company purpose
Selskabets formål er at drive virksomhed indenfor fysioterapi samt enhver hermed ligestillet virksomhed.
Address
Stationsalleen 42
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.158 | 1.474 | 2.302 | 2.199 | 2.612 | 2.997 | 2.957 | 4.014 |
| Staff expenses | -353 | -534 | -527 | -499 | -418 | -457 | -365 | -1.835 |
| EBITDA | 806 | 939 | 1.775 | 1.700 | 2.193 | 2.535 | 2.591 | 2.179 |
| Depreciation & amort. | -640 | -853 | -853 | -853 | -853 | -703 | -653 | -653 |
| EBIT | 166 | 86 | 922 | 847 | 1.340 | 1.831 | 1.938 | 1.525 |
| Net financials | -410 | -465 | -368 | -246 | -205 | -230 | -356 | -387 |
| Profit before tax | -244 | -379 | 554 | 601 | 1.136 | 1.602 | 1.582 | 1.139 |
| Tax | -54 | -83 | 122 | 132 | 250 | 353 | 348 | 251 |
| Net profit | -191 | -296 | 432 | 469 | 885 | 1.248 | 1.233 | 888 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 10.903 | 10.251 | 9.348 | 8.623 | 9.643 | 8.832 | 8.611 | 9.820 |
| Equity | -141 | -436 | -4 | 464 | 1.000 | 1.498 | 1.581 | 1.269 |
| Long-term debt | 8.292 | 7.990 | 6.849 | 5.450 | 5.529 | 4.481 | 3.796 | 5.384 |
| Short-term debt | 2.655 | 2.505 | 2.157 | 2.127 | 2.285 | 1.861 | 2.070 | 2.140 |
| Total debt | 10.947 | 10.495 | 9.006 | 7.576 | 7.814 | 6.342 | 5.866 | 7.525 |
EBITDA margin
54.3%
This company
15.8%
Market median
+244% vs market
20172024
Equity ratio
12.9%
This company
38.2%
Market median
-66% vs market
20172024
Return on equity
70.0%
This company
18.4%
Market median
+280% vs market
20172024
Net profit margin
22.1%
This company
8.1%
Market median
+173% vs market
20172024
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20172024
Debt / equity
6.74×
This company
0.62×
Market median
-987% vs market
20172024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-02-20 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NS Management | Management | 2018 | — | — |
TJ Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ProTreatment Holding ApS | Company | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ProTreatment Holding ApS
ProTreatment Herlev ApS Board members of ProTreatment Herlev ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nadia Seistrup | Management | 0 companies |
| Thomas Jørgensen | Chief Executive Officer | 0 companies |